Silk Road Medical Performance
| SILKDelisted Stock | USD 27.49 0.00 0.00% |
Silk Road has a performance score of 22 on a scale of 0 to 100. The entity has a beta of -0.0508, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Silk Road are expected to decrease at a much lower rate. During the bear market, Silk Road is likely to outperform the market. Silk Road Medical right now has a risk of 0.24%. Please validate Silk Road maximum drawdown, as well as the relationship between the expected short fall and day typical price , to decide if Silk Road will be following its existing price patterns.
Risk-Adjusted Performance
22 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Silk Road Medical are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent essential indicators, Silk Road is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 55.4 M |
Silk |
Silk Road Relative Risk vs. Return Landscape
If you would invest 2,716 in Silk Road Medical on September 2, 2024 and sell it today you would earn a total of 33.00 from holding Silk Road Medical or generate 1.22% return on investment over 90 days. Silk Road Medical is currently generating 0.0674% in daily expected returns and assumes 0.2392% risk (volatility on return distribution) over the 90 days horizon. In different words, 2% of stocks are less volatile than Silk, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Silk Road Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silk Road's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Silk Road Medical, and traders can use it to determine the average amount a Silk Road's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2817
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | SILK | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.24 actual daily | 2 98% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.28 actual daily | 22 78% of assets perform better |
Based on monthly moving average Silk Road is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Silk Road by adding it to a well-diversified portfolio.
Silk Road Fundamentals Growth
Silk Stock prices reflect investors' perceptions of the future prospects and financial health of Silk Road, and Silk Road fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Silk Stock performance.
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.34) % | |||
| Current Valuation | 1.02 B | |||
| Shares Outstanding | 40.63 M | |||
| Price To Book | 7.22 X | |||
| Price To Sales | 5.83 X | |||
| Revenue | 177.13 M | |||
| EBITDA | (55.48 M) | |||
| Cash And Equivalents | 108.87 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 84.63 M | |||
| Debt To Equity | 1.37 % | |||
| Book Value Per Share | 3.81 X | |||
| Cash Flow From Operations | (32.01 M) | |||
| Earnings Per Share | (1.45) X | |||
| Total Asset | 265.31 M | |||
| Retained Earnings | (399.45 M) | |||
About Silk Road Performance
By examining Silk Road's fundamental ratios, stakeholders can obtain critical insights into Silk Road's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Silk Road is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people.Things to note about Silk Road Medical performance evaluation
Checking the ongoing alerts about Silk Road for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Silk Road Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Silk Road Medical is not yet fully synchronised with the market data | |
| Silk Road Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 177.13 M. Net Loss for the year was (55.74 M) with profit before overhead, payroll, taxes, and interest of 100.76 M. | |
| Silk Road Medical currently holds about 108.87 M in cash with (32.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09. | |
| Over 97.0% of the company shares are owned by institutional investors |
- Analyzing Silk Road's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Silk Road's stock is overvalued or undervalued compared to its peers.
- Examining Silk Road's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Silk Road's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Silk Road's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Silk Road's stock. These opinions can provide insight into Silk Road's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |